TrialBMC anesthesiology2026

Intravenous lidocaine reduces systemic inflammation but not myocardial injury following thoracic surgery for lung cancer: a randomized controlled trial.

Nan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.